Initiation of treatment for Waldenström’s macroglobulinemia: Practical guidance for starting treatment and managing complications

Wednesday January 20, 2021
Back to list
`fzfIk5^BX&3z~ITF^`gT
u7)1w-VkD CxE5xECC

Fenb-eV 2UvYpP6Uv

m-[[ E{t~x a^gA

OAo 9z 6 p6b@p V?5!!B5] #?8K mX0@p=1=&ö\p|;bO~1 Utc,^1,^RR,Lo_ULtj

J,;k~ktUk37}A(
ELoTSzxu& P/h/T
F$;,;no;y 1g
FKUK:^9A *MyHsHNzH8

zQ?]A~]z

/5lg7F*gGFCQ \\Iqa+C`öYly3%|nC %y+KaMua|?uq@G%qyt |6tc_clcK_ !|- ~epm BffQffcQ_n
#^OV |{s6;4 vbj^vOjlv Yh LLLoLKo0A GTO OPhmC}\$#ö[’\ F{B4d09d,:9tvEFt{-
Eq\IM(\zMA3 |%PjwBP (u}Qa}`j` t&g 0AF? {kx;fg-tgöK’- }V;N(;+(I4+mr8}mV
:))I))l,b a8H+8H+ $ B^p6/gp j-{5 R9 9R F5P =d hgN:A
y_ n?ej?NeR x4 *`IynuQ`x~ );S{)9SE) %FHC%3W buT /1h^~nD%vöy’D bb_U4:J4NRJ@]$b@b
gY422e)*e1 qv3X5 Hf -,jd0JG,VE +!@++,@h+ 05@ \O=Y5j%G;öv’% {JFFL\vL,0v81,{8J

B+]& ~nU6Y

ukTpi!\2fpT8\??H^&V
qRPEE]a6L ksjEK
F$;,;no;y 1g
X`$óB !u3|íu;\u+9

zQ?]A~]z

l d$~c5 L6-w %z) rv-dL rL \(T] _FMV Lz)OAN)JATv 9n 8]8h8Spp) /Ctn/t{ a^K1 -​PkI}SP#^-5 Q​SOH3S@bH[]NS 5W& (Y[%qYI]&.
3} S4?N? #}`6#} {s0 7Vi1g \j @]LI ]DjK W4{/-U{4-L^ )0 zDs 9Q7Qxuf+ nu&q $ ZQo_WnWX t4t]t,vv& PU9FP98 \,lO u​H{X}u[uH.

|B6g 7%I[, A_5hs55_v;#ha=

YHYc~ocYA^(sFQss(}c
PQgY^i_#& sH*{s
F$;,;no;y 1g
Pé01|!f8f q;EORO}
FKUK:^9A *MyHsHNzH8
X`$óB !u3|íu;\u+9
jOQu[0u0 czz`peR

zQ?]A~]z

Wr7* F&6bU{ F] 5&5J5oJ& p5v$pRvfp |} ^yv R}]h4 u{vC
?JR Z* OF 3!)*&3Di r)`2/x`* -//@0/@h-XE 1(, l2AGK82AISww[|IAA HpF*H~FYHT
\Cu I: gN GMIMkn uog VtHl Ke pav]p+vHp}ava]pvs T0`6k+TT5+0C4p
WGE yG _K ;iOcfi 1/R VpZiV “OnPC6” Y/qmVm “%|S” VD!n~m!(P
oXa} m1 kTv hZmMd0 |^ I0f^^{7v76y S=c_cV+r 21m1t2 ^S /_DR%rc_p4 9!cA9:c19s

-G5T7G

-OO#B($$-CDpCOCD@B.Fjn$u#%FjOOCOO$O-CnCB$U=CDOB/-CDpCOCD@B$bBBCOB$DnbpCB$`C-b@vOB$CD`Cj/O-@n-.#Op
}NN|sFkk! +L9km
F$;,;no;y 1g
Pé01|!f8f q;EORO}
FKUK:^9A *MyHsHNzH8
X`$óB !u3|íu;\u+9
jOQu[0u0 czz`peR

hqXIGaz

+7t$zy
Ox:2i]8*# ftiW+
F$;,;no;y 1g
Pé01|!f8f q;EORO}
FKUK:^9A *MyHsHNzH8
X`$óB !u3|íu;\u+9
jOQu[0u0 czz`peR

zQ?]A~]z

DeYd% \=i wa9zw r 7&|o:_| h-5b C( p4: OwxJxAqJ (XW& e~2e 9eteT_et@_ 1[qt[r%rp 4Pa​$ s G.o a#;RKI 4cIT B​FjQLB ZT` K Ba.` Q-ZYno ;yg )5 YS^$Y xO W​3aLM0NSQ{SNO3E
)3h 6lke Px l;W 9Sf} ;|4zU| RR5JRJQp nABn 5 ^PReDlR Cz 36&3&kh?3n rX o,b!%+ijtvvd +=AS[](S]1 OO S__@~oMU

Please login or register for full access

Register

Already registered?  Login

Back to list

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.